---
figid: PMC7385662__nihms-1611352-f0001
figlink: pmc/articles/PMC7385662/figure/F1/
number: F1
caption: Acute opioid binding to the μ-opioid receptor inhibits the downstream cAMP
  (A), which recovers with chronic opioid use and further increases in withdrawal,
  leading to excess NE discharge from the noradrenergic neurons in the locus coeruleus
  (B). Therefore, treatment of withdrawal involves either attenuating the cAMP pathway
  through μ-opioid receptor agonism (A) or inhibiting excess NE discharge from locus
  coeruleus neurons through presynaptic α2-receptor agonism. ATP=adenosine triphosphate.
  cAMP=cyclic adenosine monophosphate. PKA=protein kinase A. NE=norepinephrine. *Not
  approved by the US Food and Drug Administration yet.
pmcid: PMC7385662
papertitle: New directions in the treatment of opioid withdrawal.
reftext: A Benjamin Srivastava, et al. Lancet. ;395(10241):1938-1948.
pmc_ranked_result_index: '52179'
pathway_score: 0.9380057
filename: nihms-1611352-f0001.jpg
figtitle: New directions in the treatment of opioid withdrawal
year: ''
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7385662__nihms-1611352-f0001.html
  '@type': Dataset
  description: Acute opioid binding to the μ-opioid receptor inhibits the downstream
    cAMP (A), which recovers with chronic opioid use and further increases in withdrawal,
    leading to excess NE discharge from the noradrenergic neurons in the locus coeruleus
    (B). Therefore, treatment of withdrawal involves either attenuating the cAMP pathway
    through μ-opioid receptor agonism (A) or inhibiting excess NE discharge from locus
    coeruleus neurons through presynaptic α2-receptor agonism. ATP=adenosine triphosphate.
    cAMP=cyclic adenosine monophosphate. PKA=protein kinase A. NE=norepinephrine.
    *Not approved by the US Food and Drug Administration yet.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKACG
  - PRKAR1A
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKAR1B
  - Buprenorphine
  - Methadone
  - Tramadol
  - Adenylyl
  - Clonidine
  - Lofexidine
  - Tizanidine
genes:
- word: РКА
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: РКА
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: РКА
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: РКА
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: РКА
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: РКА
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: РКА
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
chemicals:
- word: Buprenorphine
  source: MESH
  identifier: D002047
- word: Methadone
  source: MESH
  identifier: D008691
- word: Tramadol
  source: MESH
  identifier: D014147
- word: Adenylyl
  source: MESH
  identifier: C015492
- word: Clonidine
  source: MESH
  identifier: D003000
- word: Lofexidine
  source: MESH
  identifier: C025655
- word: Tizanidine
  source: MESH
  identifier: C023754
diseases: []
figid_alias: PMC7385662__F1
redirect_from: /figures/PMC7385662__F1
figtype: Figure
---
